Phase I trial of high-dose tamoxifen as a modulator of drug resistance in combination with daunorubicin in patients with relapsed or refractory acute leukemia. [electronic resource]
Producer: 19951107Description: 1631-7 p. digitalISSN:- 0887-6924
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Daunorubicin -- administration & dosage
- Drug Administration Schedule
- Drug Resistance, Multiple
- Female
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Tamoxifen -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.